Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights - Scorecard - MDSpire

Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights

  • By

  • Xue Ren

  • Feng Shang

  • Defu Yang

  • Ying Yan

  • Ying Xu

  • April 22, 2026

  • 0 min

Share

Clinical Scorecard: Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights

At a Glance

CategoryDetail
Condition
Key MechanismsIndividualized concurrent chemoradiotherapy approach with TMZ and EP chemotherapy, as detailed in the case study.
Target Population
Care Setting

Key Highlights

  • overall_survival

Guideline-Based Recommendations

Diagnosis

    Management

    • Use of Stupp regimen for GBM treatment as per NCCN guidelines.
    • Concurrent chemotherapy with EP for SCLC, referencing NCCN guidelines.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Include treatment timeline and any relevant biomarkers identified during treatment.

        Clinical Best Practices

        • additional_details

        References

        Original Source(s)

        Concurrent Diagnosis of Small Cell Lung Cancer Following Glioblastoma Recurrence: A Case Study on Tailored Chemoradiotherapy Approaches and Clinical Insights

        • by Xue Ren, Feng Shang, Defu Yang, Ying Yan, Ying Xu

        • April 22, 2026

        Related Content

        Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

        Synthetic short RNA in cancer

        Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases